DUBLIN–(BUSINESS WIRE)–The “Global Vision Care Market: Size, Trends and Forecast (2019-2023)” report has been added to ResearchAndMarkets.com’s offering. Global Vision Care Market: Size, Trends and Forecast (2019-2023) provides an in-depth analysis of the vision care market including a detailed description of market sizing and growth. The report provides an analysis of the global vision care market by value and by segments. The report also includes a detailed segment analysis of the vision ca
Category: Business
Researchers Study Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
LOS ANGELES–(BUSINESS WIRE)–Improvement in Patient Compliance and Screening Efficacy by Using the EyeArt AI Eye Screening System for Detecting Diabetic Retinopathy
International Study Confirms Significant, Sustained IOP and Medication Reduction Following Standalone Implantation of Glaukos’ iStent inject® in Glaucoma Patients with Substantial Disease Burden
SAN CLEMENTE, Calif.–(BUSINESS WIRE)–Glaukos Corporation (NYSE: GKOS), an ophthalmic medical technology and pharmaceutical company focused on the development and commercialization of novel surgical devices and sustained pharmaceutical therapies desig…
Allegro Ophthalmics Announces Positive Topline Vision Results of Phase 2 Study Evaluating Risuteganib in Patients with Intermediate Dry Age-Related Macular Degeneration
SAN JUAN CAPISTRANO, Calif.–(BUSINESS WIRE)–<a href="https://twitter.com/hashtag/DME?src=hash" target="_blank">#DME</a>–Allegro Ophthalmics today announced positive topline results of its U.S. Phase 2 study of risuteg…
Eine der größten Diabetes-Klinken Deutschlands überprüft jährlich 20.000 Patienten mit AI-unterstütztem Augen-Screening-System EyeArt auf diabetische Retinopathie
LOS ANGELES–(BUSINESS WIRE)–Eine der größten Diabetes-Klinken Deutschlands überprüft jährlich 20.000 Patienten mit AI-unterstütztem Augen-Screening-System EyeArt auf diabetische
Fabrinet to Present at Upcoming Investor Conferences
BANGKOK–(BUSINESS WIRE)–Fabrinet (NYSE: FN), a leading provider of advanced optical packaging and precision optical, electro-mechanical and electronic manufacturing services to original equipment manufacturers of complex products, today announced tha…
Global Surgical Lasers Market to Surpass US$ 2 Billion by 2026 – Coherent Market Insights
SEATTLE–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/DiodeLaser?src=hash" target="_blank"gt;#DiodeLaserlt;/agt;–According to Coherent Market Insights, the global surgical lasers market was valued at US$ …
Aerie Pharmaceuticals to Present at the Jefferies 2019 Healthcare Conference
DURHAM, N.C.–(BUSINESS WIRE)–Aerie Pharmaceuticals, Inc. (NASDAQ:AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with open-angle glaucom…
Aura Biosciences to Present at the Jefferies 2019 Global Healthcare Conference
CAMBRIDGE, Mass.–(BUSINESS WIRE)–Aura Biosciences today announced that CEO Elisabet de los Pinos, Ph.D., will present at the Jefferies 2019 Global Healthcare Conference.
Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025 – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Global Ophthalmology Market by Segment, Disease, Drug Class, and Region – Outlook to 2025” report has been added to ResearchAndMarkets.com’s offering. Treatment paradigm of eye disorders primarily aims to reduce inflammation, repairs traumatic injuries, and improves or saves eyesight. Treatment comprises of medication, surgery, prescription glasses or contact lenses and treatment of systemic conditions affecting the eye. Prevalence of eye disorders has been increas
NovaBay Pharmaceuticals Receives NYSE American Communication
EMERYVILLE, Calif.–(BUSINESS WIRE)–NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY), a biopharmaceutical company focusing on commercializing prescription Avenova® for the domestic eye care market, announces that on May 16, 2019 it received notice …
最新科学研究显示，首尔半导体SunLike系列自然光谱LED可提升视觉舒适感、日间警觉性、情绪和睡眠深度
韩国安山–(BUSINESS WIRE)–最新科学研究显示，首尔半导体SunLike系列自然光谱LED可提升视觉舒适感、日间警觉性、情绪和睡眠深度
ソウル半導体のSunLike LED、研究により視覚快適性、昼間の覚醒度、気分と睡眠への効果を確認
韓国安山市–(BUSINESS WIRE)–ソウル半導体のSunLike LED、研究により視覚快適性、昼間の覚醒度、気分と睡眠への効果を確認
Ocular Therapeutix™ Announces Topline Results of Phase 3 Clinical Trial of OTX-TP for the Treatment of Glaucoma
BEDFORD, Mass.–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24OCUL&src=ctag" target="_blank"gt;$OCULlt;/agt; lt;a href="https://twitter.com/hashtag/OCUTX?src=hash" target=&…
The World Market for Ophthalmoscopes (2019-2027) by Type, Application, End-user and Geography – ResearchAndMarkets.com
DUBLIN–(BUSINESS WIRE)–The “Ophthalmoscopes Market to 2027- Global Analysis and Forecasts By Type, Application, End User, and Geography” report has been added to ResearchAndMarkets.com’s offering. The global ophthalmoscopes market is expected to reach US$ 322.13 Mn in 2027 from US$ 216.79 in 2018. The ophthalmoscopes market is estimated to grow with a CAGR of 4.6% from 2019-2027. The market is driven by the factors such as, rising prevalence of eye diseases in developing and developed nations
德國糖尿病診所部署Eyenuk的EyeArt AI眼疾篩檢系統後，糖尿病視網膜病變檢出數由零增至數千例
洛杉磯–(BUSINESS WIRE)–(美國商業資訊) — Eyenuk Inc.是一家全球性人工智慧(AI)醫療技術及服務公司，也是AI Eye Screening™在真實世界應用的領先者，該公司今天發布了其進軍德國的成果。自從2018年10月採納EyeArt AI眼疾篩檢系統，梅根罕糖尿病中心(Diabetes Center Mergentheim)已篩檢數千例糖尿病人，確認約10%的病例有需要轉診的糖尿病視網膜病變(DR)。該中心是德國首家專門採用人工智慧篩檢DR的糖尿病診所，DR是工…
德国糖尿病诊所部署Eyenuk的EyeArt AI眼病筛查系统后，糖尿病视网膜病变检出数由零增至数千例
洛杉矶–(BUSINESS WIRE)–(美国商业资讯) — Eyenuk Inc.是一家全球性人工智能(AI)医疗技术及服务公司，也是AI Eye Screening™在真实世界应用的领先者，该公司今天发布了其进军德国的成果。自从2018年10月采纳EyeArt AI眼病筛查系统，梅根特海姆糖尿病中心(Diabetes Center Mergentheim)已筛查数千例糖尿病人，确认约10%的病例有需要转诊的糖尿病视网膜病变(DR)。该中心是德国首家专门采用人工智能筛查DR的糖尿病诊所，DR…
Clínica alemã de diabetes aumenta triagens de retinopatia diabética de zero a milhares depois de implementar o EyeArt AI Eye Screening System da Eyenuk
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., uma empresa mundial de tecnologia e serviços médicos que faz uso da inteligência artificial (IA) global e líder em aplicações reais para a AI Eye Screening™, anunciou hoje os resultados de sua expansão para a …
Clínica alemana para la diabetes aumenta los exámenes de detección de retinopatía diabética de cero a miles después de implementar sistema de exploración ocular vía IA EyeArt de Eyenuk
LOS ÁNGELES–(BUSINESS WIRE)–Eyenuk Inc., una empresa global de tecnología y servicios médicos de inteligencia artificial (IA) y líder en aplicaciones del mundo real para AI Eye Screening™, anunció hoy los resultados de su expansión hacia Alemania. De…
Samenvatting: Duitse diabeteskliniek verhoogt diabetische retinopathiescreening van nul naar duizenden na implementatie van Eyenuk’s EyeArt AI oogonderzoekssysteem
LOS ANGELES–(BUSINESS WIRE)–Eyenuk Inc., een wereldwijd opererend bedrijf op het gebied van medische technologie en kunstmatige intelligentie (AI) diensten en koploper op het gebied van praktische toepassingen voor AI Eye Screening™, kondigt vandaag …